Digital Readout Test

Online tests using scanned sample preparations

In order to monitor and further develop the interpretation of histological staining, QuIP has developed a concept of online tests in which participants are provided with a defined number of scanned sample preparations to interpret. These digital readout tests were intended to give pathologists the opportunity to check their level of knowledge while the annotations provided immediate feedback to their interpretations. 

The concept of analogous readout tests was proven successful in the Mammary Carcinoma proficiency tests. The step towards digitization of readout tests therefore enabled individualized participation with less time constraints. A format for PD-L1 scoring was developed first and launched in 2022. Parts of the Mammary Carcinoma proficiency tests, e.g. Ki-67 scoring, have now been included in the online digital readout test.  

Further offers can be found in the DRT program. See the FAQs for more information on the DRTs.

The activities on digitization in pathology are supported by the German Federal Ministry for Economic Affairs and Climate Action for a period of three years (2020 to 2023).